789 related articles for article (PubMed ID: 18848609)
1. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
[TBL] [Abstract][Full Text] [Related]
2. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
[TBL] [Abstract][Full Text] [Related]
3. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
[TBL] [Abstract][Full Text] [Related]
4. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
Papadimitriou S; Bikiaris D
J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles.
Beck-Broichsitter M; Gauss J; Gessler T; Seeger W; Kissel T; Schmehl T
J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):47-57. PubMed ID: 19778266
[TBL] [Abstract][Full Text] [Related]
6. Polymer nanoparticle-based controlled pulmonary drug delivery.
Beck-Broichsitter M; Dalla-Bona AC; Kissel T; Seeger W; Schmehl T
Methods Mol Biol; 2014; 1141():133-45. PubMed ID: 24567136
[TBL] [Abstract][Full Text] [Related]
7. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.
Beck-Broichsitter M; Rieger M; Reul R; Gessler T; Seeger W; Schmehl T
Eur J Pharm Biopharm; 2013 May; 84(1):106-14. PubMed ID: 23262166
[TBL] [Abstract][Full Text] [Related]
8. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
[TBL] [Abstract][Full Text] [Related]
9. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles.
Rytting E; Bur M; Cartier R; Bouyssou T; Wang X; Krüger M; Lehr CM; Kissel T
J Control Release; 2010 Jan; 141(1):101-7. PubMed ID: 19720096
[TBL] [Abstract][Full Text] [Related]
11. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
12. DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method.
Oster CG; Wittmar M; Bakowsky U; Kissel T
J Control Release; 2006 Apr; 111(3):371-81. PubMed ID: 16499988
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
14. Novel sustained release microspheres for pulmonary drug delivery.
Cook RO; Pannu RK; Kellaway IW
J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
[TBL] [Abstract][Full Text] [Related]
15. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
Nasr M; Awad GA; Mansour S; Taha I; Al Shamy A; Mortada ND
Eur J Pharm Biopharm; 2011 Nov; 79(3):601-11. PubMed ID: 21827854
[TBL] [Abstract][Full Text] [Related]
16. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
19. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
Rodrigues MR; Lanzarini CM; Ricci-Junior E
Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
